Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59.

Abstract:

:Functionally inhibitory antibody to the plasma membrane complement inhibitor CD59 has been used to investigate control of the terminal complement proteins at the endothelial cell surface. Antibodies against purified human erythrocyte CD59 (polyclonal anti-CD59 and monoclonal antibodies [MoAbs] 1F1 and 1F5) were found to bind specifically to monolayers of cultured human umbilical vein endothelial cells, and by Western blotting to recognize an 18- to 21-Kd endothelial protein. When bound to the endothelial monolayer, anti-CD59 (immunoglobulin G or Fab fragment) potentiated membrane pore formation induced upon C9 binding to C5b-8, and augmented the C5b-9-induced cellular responses, including stimulated secretion of von Willebrand factor and expression of catalytic surface for the prothrombinase enzyme complex. Although potentiating endothelial responses to the terminal complement proteins, anti-CD59 had no effect on the response of these cells to stimulation by histamine. Taken together, these data suggest that human endothelial cells express the CD59 cell surface inhibitor of the terminal complement proteins, which serves to protect these cells from pore-forming and cell-stimulatory effects of the C5b-9 complex. These data also suggest that the inactivation or deletion of this cell surface regulatory molecule would increase the likelihood for procoagulant changes in endothelium exposed to complement activation in plasma.

journal_name

Blood

journal_title

Blood

authors

Hamilton KK,Ji Z,Rollins S,Stewart BH,Sims PJ

subject

Has Abstract

pub_date

1990-12-15 00:00:00

pages

2572-7

issue

12

eissn

0006-4971

issn

1528-0020

journal_volume

76

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity.

    abstract::Activation of inflammatory and procoagulant mechanisms is thought to contribute significantly to the initiation of restenosis, a common complication after balloon angioplasty of obstructed arteries. During this process, expression of tissue factor (TF) represents one of the major physiologic triggers of coagulation th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1148

    authors: Kopp CW,Hölzenbein T,Steiner S,Marculescu R,Bergmeister H,Seidinger D,Mosberger I,Kaun C,Cejna M,Horvat R,Wojta J,Maurer G,Binder BR,Breuss JM,Ecker RC,de Martin R,Minar E

    更新日期:2004-03-01 00:00:00

  • Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells.

    abstract::We previously found that the myeloid cell surface glycoprotein CD13 (gp150) is identical to aminopeptidase N (EC 3.4.11.2), a widely distributed membrane-bound, zinc-dependent metalloprotease with an extracellular enzymatic domain that cleaves N-terminal amino acid residues from oligopeptides (J Clin Invest 83:1299, 1...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ashmun RA,Look AT

    更新日期:1990-01-15 00:00:00

  • Plasma cell myeloma--new biological insights and advances in therapy.

    abstract::Plasma cell myeloma is a more complex neoplasm than suggested by the relative uniformity of its dominant plasma cells, which represent the terminal stage of normal B-cell differentiation. Phenotypic, molecular, and cellular genetic data favor the presence of a myeloma stem cell early in hematopoietic development so th...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Barlogie B,Epstein J,Selvanayagam P,Alexanian R

    更新日期:1989-03-01 00:00:00

  • Erythropoietin alone induces erythroid burst formation by human embryonic but not adult BFU-E in unicellular serum-free culture.

    abstract::Erythroid progenitors (BFU-E) from adult human peripheral blood generate erythroid bursts in semisolid culture supplemented with at least two growth factors, ie, erythropoietin (Ep) and interleukin-3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF). We have analyzed the hematopoietin(s) requirement ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Valtieri M,Gabbianelli M,Pelosi E,Bassano E,Petti S,Russo G,Testa U,Peschle C

    更新日期:1989-07-01 00:00:00

  • A cytokine receptor gene cluster in the X-Y pseudoautosomal region?

    abstract::The receptors for interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF) are heterodimers comprised of ligand specific alpha chains and a common beta chain. The genes encoding the IL-5 receptor alpha chain and the common beta chain reside on chromosome 3 and 22 respectively, while th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kremer E,Baker E,D'Andrea RJ,Slim R,Phillips H,Moretti PA,Lopez AF,Petit C,Vadas MA,Sutherland GR

    更新日期:1993-07-01 00:00:00

  • Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites.

    abstract::Congenital afibrinogenemia is a rare inherited coagulopathy, characterized by very low or unmeasurable plasma levels of immunoreactive fibrinogen. So far, 25 mutations have been identified in afibrinogenemia, 17 in the Aalpha, 6 in the gamma, and only 2 in the Bbeta fibrinogen-chain genes. Here, 2 afibrinogenemic prob...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-06-1647

    authors: Spena S,Duga S,Asselta R,Malcovati M,Peyvandi F,Tenchini ML

    更新日期:2002-12-15 00:00:00

  • Deficient MHC class I cross-presentation of soluble antigen by murine neonatal dendritic cells.

    abstract::Neonates respond suboptimally to many vaccines. The reasons for this defect are unclear, but suboptimal antigen presentation by dendritic cells has been suggested as one possibility. In this report we describe an in vitro system that allows the generation of large numbers of resting murine neonatal dendritic cells fac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-11-3805

    authors: Kollmann TR,Way SS,Harowicz HL,Hajjar AM,Wilson CB

    更新日期:2004-06-01 00:00:00

  • Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes.

    abstract::Vorinostat (suberoylanilide hydroxamic acid, SAHA) is a histone deacetylase inhibitor active clinically in cutaneous T-cell lymphoma and preclinically in leukemia. A phase 1 study was conducted to evaluate the safety and activity of oral vorinostat 100 to 300 mg twice or thrice daily for 14 days followed by 1-week res...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-06-098061

    authors: Garcia-Manero G,Yang H,Bueso-Ramos C,Ferrajoli A,Cortes J,Wierda WG,Faderl S,Koller C,Morris G,Rosner G,Loboda A,Fantin VR,Randolph SS,Hardwick JS,Reilly JF,Chen C,Ricker JL,Secrist JP,Richon VM,Frankel SR,Kantarj

    更新日期:2008-02-01 00:00:00

  • Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients.

    abstract::Rh(o)(D) immune globulin intravenous (anti-D IGIV) was licensed by the United States Food and Drug Administration (FDA) in March 1995 to treat patients with immune thrombocytopenic purpura (ITP). Anti-D IGIV induces extravascular hemolysis, an expected adverse reaction that is consistent with the presumed mechanism of...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Gaines AR

    更新日期:2000-04-15 00:00:00

  • Deficient lipoxin synthesis: a novel platelet dysfunction in myeloproliferative disorders with special reference to blastic crisis of chronic myelogenous leukemia.

    abstract::The capacity to convert exogenous leukotriene A4 to lipoxins (LXs) was investigated in platelet suspensions from patients with myeloproliferative disorders (MPD) (n = 22) and healthy control subjects (n = 14). Platelets isolated from the controls produced mainly LXA4, but also 6(S)-LXA4 and the all-trans isomers of li...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Stenke L,Edenius C,Samuelsson J,Lindgren JA

    更新日期:1991-12-01 00:00:00

  • Prevention and induction of occlusive coronary vascular disease in autoimmune (W/B)F1 mice by haploidentical bone marrow transplantation: possible role for anticardiolipin autoantibodies.

    abstract::Male (NZW x BXSB)F1 (W/BF1) mice develop systemic autoimmunity involving autoantibodies, thrombocytopenia, lupus nephritis, and coronary vascular disease with myocardial infarction (CVD). To determine whether this murine lupus-associated CVD could be transferred to otherwise autoimmune-resistant (C57BL/6 x C3H/He)F1 (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mizutani H,Engelman RW,Kinjoh K,Kurata Y,Ikehara S,Good RA

    更新日期:1993-11-15 00:00:00

  • Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV.

    abstract::We describe the membrane localization of a new platelet-specific alloantigen, designated Naka, that is involved in refractoriness to HLA-matched platelet transfusions. By indirect immunoprecipitation, anti-Naka antibody precipitated a single, radiolabeled platelet membrane protein with a molecular weight (mol wt) of 9...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tomiyama Y,Take H,Ikeda H,Mitani T,Furubayashi T,Mizutani H,Yamamoto N,Tandon NN,Sekiguchi S,Jamieson GA

    更新日期:1990-02-01 00:00:00

  • Erythrocyte glycolysis and its marked alterations by muscular exercise in type VII glycogenosis.

    abstract::Levels of erythrocyte glycolytic intermediates after the phosphofructokinase (PFK) step, including 2,3-bisphosphoglycerate (2,3-DPG), were decreased at rest in patients from separate families with type VII glycogenosis. The concentration of 2,3-DPG was about half of the normal control value during a period of unrestri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Shimizu T,Kono N,Kiyokawa H,Yamada Y,Hara N,Mineo I,Kawachi M,Nakajima H,Wang YL,Tarui S

    更新日期:1988-04-01 00:00:00

  • Expression of p53 in human leukemia and lymphoma.

    abstract::Analysis of fresh human tumors have indicated that patients with B type lymphoproliferative diseases and the majority of patients with acute lymphoblastic leukemia (ALL) express elevated levels of p53 production. It is suggested that in these human malignancies, p53 may provide a novel tool for monitoring cancer activ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Prokocimer M,Shaklai M,Bassat HB,Wolf D,Goldfinger N,Rotter V

    更新日期:1986-07-01 00:00:00

  • A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka- platelets lack detectable GPIV (CD36).

    abstract::It has recently been shown that the Naka antigen, which is absent in 3% to 11% of Japanese blood donors, is expressed on platelet glycoprotein IV (GPIV; CD36) (Tomiyama et al, BLOOD, 75:684, 1990). In the present studies, flow cytometry was used to distinguish differences in the reactivity of Naka+ and Naka- platelets...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yamamoto N,Ikeda H,Tandon NN,Herman J,Tomiyama Y,Mitani T,Sekiguchi S,Lipsky R,Kralisz U,Jamieson GA

    更新日期:1990-11-01 00:00:00

  • Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential.

    abstract::The replating capability of human multipotential (colony-forming unit-granulocyte-erythrocyte-macrophage-megakaryocyte [CFU-GEMM]) and erythroid (burst-forming unit-erythroid [BFU-E]) progenitors was assessed in vitro as a potential measure of self-renewal using purified, recombinant (r) human (hu) or murine (mu) mast...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Carow CE,Hangoc G,Cooper SH,Williams DE,Broxmeyer HE

    更新日期:1991-11-01 00:00:00

  • Approach to the treatment of multiple myeloma: a clash of philosophies.

    abstract::In this Perspective, we summarize some of the most contentious issues surrounding diagnosis and treatment of myeloma. We outline how a fundamental clash of philosophies, cure versus control, may be at the heart of many of the controversies. From the very definition of the disease to risk stratification to the validity...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-297853

    authors: Rajkumar SV,Gahrton G,Bergsagel PL

    更新日期:2011-09-22 00:00:00

  • Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma.

    abstract::Bruton tyrosine kinase (Btk) has a well-defined role in B-cell development, whereas its expression in osteoclasts (OCs) further suggests a role in osteoclastogenesis. Here we investigated effects of PCI-32765, an oral and selective Btk inhibitor, on osteoclastogenesis as well as on multiple myeloma (MM) growth within ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-12-396853

    authors: Tai YT,Chang BY,Kong SY,Fulciniti M,Yang G,Calle Y,Hu Y,Lin J,Zhao JJ,Cagnetta A,Cea M,Sellitto MA,Zhong MY,Wang Q,Acharya C,Carrasco DR,Buggy JJ,Elias L,Treon SP,Matsui W,Richardson P,Munshi NC,Anderson KC

    更新日期:2012-08-30 00:00:00

  • Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.

    abstract::Multiple myeloma (MM) is associated with severe normochromic/normocytic anemia. This study demonstrates that the abnormal up-regulation of apoptogenic receptors, including both Fas ligand (L) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), by highly malignant myeloma cells is involved in the patho...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.4.1305

    authors: Silvestris F,Cafforio P,Tucci M,Dammacco F

    更新日期:2002-02-15 00:00:00

  • Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.

    abstract::Allogeneic hematopoietic stem-cell transplantation (HSCT) remains an effective strategy for inducing durable remission in chronic myeloid leukemia (CML). Reduced-intensity conditioning (RIC) regimens extend HSCT to older patients and those with comorbidities who would otherwise not be suitable candidates for HSCT. The...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-04-085969

    authors: Kebriaei P,Detry MA,Giralt S,Carrasco-Yalan A,Anagnostopoulos A,Couriel D,Khouri IF,Anderlini P,Hosing C,Alousi A,Champlin RE,de Lima M

    更新日期:2007-11-01 00:00:00

  • Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura.

    abstract::Blockade of the CD40/CD154 signal is a potential immunomodulatory strategy for T-cell-mediated diseases. As a part of a phase 1, multicenter, dose-escalating trial of humanized monoclonal antibody to CD154 (IDEC-131/E6040) in patients with refractory immune thrombocytopenic purpura (ITP), the autoimmune response to gl...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2003-06-2167

    authors: Kuwana M,Nomura S,Fujimura K,Nagasawa T,Muto Y,Kurata Y,Tanaka S,Ikeda Y

    更新日期:2004-02-15 00:00:00

  • Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.

    abstract::Ad.CMV-CD is a replication incompetent adenoviral vector carrying a cytomegalovirus (CMV)-driven transcription unit of the cytosine deaminase (CD) gene. The CD transcription unit in this vector catalyzes the deamination of the nontoxic pro-drug, 5-fluorocytosine (5-FC), thus converting it to the cytotoxic drug 5-fluor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Garcia-Sanchez F,Pizzorno G,Fu SQ,Nanakorn T,Krause DS,Liang J,Adams E,Leffert JJ,Yin LH,Cooperberg MR,Hanania E,Wang WL,Won JH,Peng XY,Cote R,Brown R,Burtness B,Giles R,Crystal R,Deisseroth AB

    更新日期:1998-07-15 00:00:00

  • 14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling.

    abstract::Members of the 14-3-3 family of proteins function as adapters/modulators that recognize phosphoserine/phosphothreonine-based binding motifs in many intracellular proteins and play fundamental roles in signal transduction pathways of eukaryotic cells. In platelets, 14-3-3 plays a wide range of regulatory roles in phosp...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-09-742650

    authors: Chen Y,Ruggeri ZM,Du X

    更新日期:2018-05-31 00:00:00

  • A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation.

    abstract::A novel thrombin inhibitor based on single-stranded (ss) deoxynucleotides with the sequence GGTTGGTGTGGTTGG (thrombin aptamer) has been recently discovered. In this study, we tested its efficacy in inhibiting clot-bound thrombin activity and platelet thrombus formation in an ex vivo whole artery angioplasty model. The...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Li WX,Kaplan AV,Grant GW,Toole JJ,Leung LL

    更新日期:1994-02-01 00:00:00

  • In vivo expansion of cells expressing acquired CSF3R mutations in patients with severe congenital neutropenia.

    abstract::Severe congenital neutropenia (CN) is a rare bone marrow failure syndrome with a high incidence of acute leukemia. In previous studies, we could show that point mutations in the gene for the granulocyte colony-stimulating factor (G-CSF) receptor CSF3R are a highly predictive marker for leukemic development in CN patie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-09-178087

    authors: Germeshausen M,Welte K,Ballmaier M

    更新日期:2009-01-15 00:00:00

  • TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.

    abstract::Proinflammatory cytokines such as TNFα are elevated in patients with myeloproliferative neoplasms (MPN), but their contribution to disease pathogenesis is unknown. Here we reveal a central role for TNFα in promoting clonal dominance of JAK2(V617F) expressing cells in MPN. We show that JAK2(V617F) kinase regulates TNFα...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-04-348144

    authors: Fleischman AG,Aichberger KJ,Luty SB,Bumm TG,Petersen CL,Doratotaj S,Vasudevan KB,LaTocha DH,Yang F,Press RD,Loriaux MM,Pahl HL,Silver RT,Agarwal A,O'Hare T,Druker BJ,Bagby GC,Deininger MW

    更新日期:2011-12-08 00:00:00

  • Erythropoiesis-stimulating factor production by rabbit kidney cultures from "programmed" rabbits.

    abstract::Rabbit kidney tissue either from normal rabbits or from rabbits "programmed" by phlebotomy or varying periods of hypoxia was cultured and shown to release into the culture medium an erythropoietically active substance. The cultures established from rabbits programmed by 6-12 hr of hypoxia yielded the highest levels of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ogle JW,Lange RD,Dunn CD

    更新日期:1978-07-01 00:00:00

  • Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT.

    abstract::A polymorphic variant of the phosphatase PTPN22 has been associated with increased risk for multiple autoimmune diseases. The risk allele is thought to function by diminishing antigen-receptor signals responsible for negative selection of autoreactive lymphocytes. We now show that PTPN22 is markedly overexpressed in c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-403162

    authors: Negro R,Gobessi S,Longo PG,He Y,Zhang ZY,Laurenti L,Efremov DG

    更新日期:2012-06-28 00:00:00

  • Global gene expression analysis of human erythroid progenitors.

    abstract::Understanding the pattern of gene expression during erythropoiesis is crucial for a synthesis of erythroid developmental biology. Here, we isolated 4 distinct populations at successive erythropoietin-dependent stages of erythropoiesis, including the terminal, pyknotic stage. The transcriptome was determined using Affy...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-290825

    authors: Merryweather-Clarke AT,Atzberger A,Soneji S,Gray N,Clark K,Waugh C,McGowan SJ,Taylor S,Nandi AK,Wood WG,Roberts DJ,Higgs DR,Buckle VJ,Robson KJ

    更新日期:2011-03-31 00:00:00

  • Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia.

    abstract::The effect of hydroxyurea in 35 patients with chronic granulocytic leukemia (CGL), who either had entered an accelerated phase of the disease or had experienced excessive myelosuppression following alkylating agents, was studied. By either intravenous or oral administration, the drug was successful in reducing periphe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schwartz JH,Cannellos GP

    更新日期:1975-07-01 00:00:00